SIBN Company Profile and Key Details

Short-term trend indicators are mixed aligned (SMA20 3.34%, SMA50 -8.04%, SMA200 -5.29%). The stock’s 14-day RSI is 50.11 (neutral), while the ATR of 0.69 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -25.86% below its high and over 29.89% above its low. Average 10-day trading volume of 615.44 thousand shares is slightly above the 3-month average of 522.97 thousand, indicating heightened recent market interest.

SI-BONE, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.04. This means the shares are trading below this model’s fair value.

SI-BONE, Inc. has 43.14 million shares outstanding. The public float is 39.25 million shares, elevated short interest at 4.89% of float. This equals 2.05 million shares. The short ratio is 4.52 days. Institutional investors hold 109.32% of the float. Insiders own 3.29%. FRANCIS LAURA holds 544.37 thousand shares, PISETSKY MICHAEL A. has 285.97 thousand shares and Maheshwari Anshul has 266.47 thousand shares. Over the past six months, insider transactions show net selling. They sold 162.75 thousand shares across 27 transactions.

SI-BONE, Inc. generated EPS of -$0.44 over the past year. Five-year average earnings growth is 21.79%. Wall Street analysts project EPS growth of 16.08% annually over the next five years. The latest quarter delivered EPS of -$0.11. The next quarter is forecast at -$0.19. Next year's EPS is expected at $13.97. Analyst sentiment is bullish. Analyst rating data shows there are 2 Strong Buy ratings, 8 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $27.00 to $20.00. The high target offers 95.23% upside. The low target suggests 44.61% downside. The mean target is $23.40. This offers 69.2% upside. SI-BONE, Inc. earnings surprise history is frequent misses against expectations. The quarter that ended November 10, 2025, missed forecasts by -33.93%. The prior quarter beat by -26.32%. Over the last six quarters, Apple has recorded several small beats. These include -15.38% in August 05, 2024.

SI-BONE, Inc. (NASDAQ:SIBN) closed at $13.83 USD, losing -$0.24 (-1.71%) from the previous close of $14.07. The stock is currently mid-range between its 52-week high and low $12.50 and $21.89. With a market capitalization of about $610.81 million, SI-BONE, Inc. is classified as a small-cap and shows lower-than-market volatility (beta ~0.69). Key stats such as the average daily volume over the past year has been around 543.91 thousand shares, in line with its 52-week average. Headquartered in Santa Clara, CA, SI-BONE, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Laura A. Francis, the company employs approximately 349 people and listed since October 17, 2018. SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally.

SI-BONE, Inc. (NASDAQ:SIBN) shares are down -14.15% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows SI-BONE, Inc. trading at a premium to the broader market with a P/E of -31.99. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $25.54, suggesting 84.67% upside. Our AI forecast model points to short-term strength (2.1% over two weeks), a medium-term rise (20.82% over three months), and a longer-term gain (14.24% over one year), with expected trading ranges indicating moderate volatility.

SI-BONE, Inc. trades at a P/E ratio of -31.99, slightly below the S&P 500 average, with a price-to-sales ratio of 3.06 and a price-to-book ratio of 3.41 trading at moderately above to book value. The P/FCF stands at -67.56, also below market averages.

Our AI price prediction model suggests that SI-BONE, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 2.1%, with price expected at $14.12 by March 20, 2026, within a range of $13.79 to $14.44 3-Month Outlook: Projected rise of 20.82%, reaching $16.71 by June 04, 2026, with a range of $15.50 to $17.63. 1-Year Outlook: Projected gain of 14.24%, with price at $15.80 by March 05, 2027, within a range of $0.31 to $22.19.